ATHEROGENICS INC 4
4 · ATHEROGENICS INC · Filed Oct 22, 2003
Insider Transaction Report
Form 4
ATHEROGENICS INCAGIX
SCOTT ROBERT A
Sr VP Clinical Dev & RA
Transactions
- Exercise/Conversion
Incentive Stock Option
2003-10-21$7.04/sh−21,600$152,064→ 58,400 totalExercise: $7.04Exp: 2012-08-30→ Common Stock (21,600 underlying) - Exercise/Conversion
Common Stock
2003-10-21$7.04/sh+21,600$152,064→ 21,600 total
Footnotes (1)
- [F1]25% of these options vested on 8/30/03, the first anniversary of the date of grant. Following that date, the remaining options vest at a rate of 2%-3% per month over the next 36 months.